Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study

Life Sciences

Volumn 122, Issue , 2015, Pages 42-50

  Cortes, Natalie ^a   Posada Duque, Rafael Andrés ^a   Alvarez, Rafael ^a   Alzate, Fernando ^a   Berkov, Strahil ^b   Cardona Gómez, Gloria Patricia ^a   Osorio, Edison ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b INSTITUTE OF BIODIVERSITY AND ECOSYSTEM RESEARCH   (Bulgaria)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Amaryllidaceae alkaloids; Neuroprotective activity

Indexed keywords

ACETYLCHOLINESTERASE; AMARYLLIDACEAE ALKALOID; GALANTAMINE; GLUTAMIC ACID; LACTATE DEHYDROGENASE; ALKALOID; CHOLINESTERASE INHIBITOR; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

AMARYLLIDACEAE; ANIMAL CELL; ARTICLE; BRAIN CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CRINUM; CRINUM BULBISPERMUM; CRINUM JAGUS; DRUG CYTOTOXICITY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPEASTRUM BARBATUM; HIPPEASTRUM PUNICEUM; IC50; IN VITRO STUDY; MASS FRAGMENTOGRAPHY; NEUROPROTECTION; NONHUMAN; RAT; ZEPHYRANTHES CARINATA; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; LILIACEAE; METABOLISM; NERVE CELL; WESTERN BLOTTING; WISTAR RAT;

AMARYLLIDACEAE; CRINUM BULBISPERMUM; CRINUM JAGUS; ELECTROPHORUS ELECTRICUS; HIPPEASTRUM; HIPPEASTRUM PUNICEUM; RATTUS; ZEPHYRANTHES CARINATA;

ACETYLCHOLINESTERASE; ALKALOIDS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; EMBRYO, MAMMALIAN; FLUORESCENT ANTIBODY TECHNIQUE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; L-LACTATE DEHYDROGENASE; LILIACEAE; NEURONS; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84920134535     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.12.011     Document Type: Article

References (40)

1. E.A. Adewusi, G. Fouche, and V. Steenkamp Cytotoxicity and acetylcholinesterase inhibitory activity of an isolated crinine alkaloid from Boophane disticha (Amaryllidaceae) J. Ethnopharmacol. 143 2012 572 578
2. D. Alzheimer's Association Alzheimer's disease facts and figures Alzheimers Dement. 8 2012 131 168
3. O.N. Bae, K. Serfozo, S.H. Baek, K.Y. Lee, A. Dorrance, W. Rumbeiha, S.D. Fitzgerald, M.U. Farooq, B. Naravelta, A. Bhatt, and A. Majid Safety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke Stroke 44 2013 205 212
4. G. Banker, and K. Goslin Culturing Nerve Cells 2th ed. 1998 MIT Press Cambridge
5. N. Bassil, and G.T. Grossberg Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease CNS Drugs 23 2009 293 307
6. J. Bastida, R. Lavilla, and F. Viladomat Chemical and biological aspects of Narcissus alkaloids G.A. Cordell, The Alkaloids Chemistry and Biology 2006 Elsevier-Academic Press Amsterdam 87 179
7. S. Berkov, J. Bastida, B. Sidjimova, F. Viladomat, and C. Codina Phytochemical differentiation of Galanthus nivalis and Galanthus elwesii (Amaryllidaceae): a case study Biochem. Syst. Ecol. 36 2008 638 645
8. S. Berkov, V. Martinez-Frances, J. Bastida, C. Codina, and S. Rios Evolution of alkaloid biosynthesis in the genus Narcissus Phytochemistry 99 2014 95 106
9. F. Chen, W. Qi, J. Sun, J.W. Simpkins, and D. Yuan Urinary metabolites of isorhynchophylline in rats and their neuroprotective activities in the HT22 cell assay Fitoterapia 97 2014 156 163
10. A. Cherubinia, C. Ruggieroa, M.C. Polidorib, and P. Mecoccia Potential markers of oxidative stress in stroke Free Radic. Biol. Med. 39 2005 841 852
11. N. Cortes, R. Alvarez, E.H. Osorio, F. Alzate, S. Berkov, and E. Osorio Alkaloid metabolite profiles by GC/MS and acetylcholinesterase inhibitory activities with binding-mode predictions of five Amaryllidaceae plants J. Pharm. Biomed. Anal. 102 2015 222 228
12. J.P. de Andrade, S. Berkov, F. Viladomat, C. Codina, J.A.S. Zuanazzi, and J. Bastida Alkaloids from Hippeastrum papilio Molecules 16 2011 7097 7104
13. E.E. Elgorashi, G.I. Stafford, and J. Van Staden Acetylcholinesterase enzyme inhibitory effects of amaryllidaceae alkaloids Planta Med. 70 2004 260 262
14. E.E. Elgorashi, S.F. Malan, G.I. Stafford, and J. van Staden Quantitative structure-activity relationship studies on acetylcholinesterase enzyme inhibitory effects of Amaryllidaceae alkaloids Afr. J. Bot 72 2006 224 231
15. I. Figiel Cellular and molecular correlates of glutamate-evoked neuronal programmed cell death in the in vitro cultures of rat hippocampal dentate gyrus Neurochem. Int. 31 1997 229 240
16. J.C. Gallego-Gómez, C. Risco, D. Rodríguez, P. Cabezas, S. Guerra, J.L. Carrascosa, and M. Esteban Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells J. Virol. 77 2003 10606 10622
17. J. Gutiérrez, J.F. Castro, D. Velásquez, M.N. Montañez, A. Céspedes, and G.P. Cardona Rac1 activity changes are associated with neuronal pathology and spatial memory long-term recovery after global cerebral ischemia Neurochem. Int. 57 2010 762 773
18. M.R. Hynd, H.L. Scott, and P.R. Dodd Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease Neurochem. Int. 45 2004 583 595
19. K. Ito, S. Ahadieh, B. Corrigan, J. French, T. Fullerton, and T. Tensfeldt Disease progression meta-analysis model in Alzheimer's disease Alzheimers Dement. 6 2010 39 53
20. L.M. Ittner, and J. Gotz Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease Nat. Rev. Neurosci. 12 2011 65 72
21. A. Jin, X. Li, Y.Y. Zhu, H.Y. Yu, H.F. Pi, P. Zhang, and H.L. Ruan Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl and H O -induced SH-SY5Y cell injuries Arch. Pharm. Res. 37 2014 315 323
22. T. Kihara, H. Sawada, T. Nakamizo, R. Kanki, H. Yamashita, A. Maelicke, and S. Shimohama Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity Biochem. Biophys. Res. Commun. 325 2004 976 982
23. X. Li, H.Y. Yu, Z.Y. Wang, P. Zhang, and H.L. Ruan Neuroprotective compounds from the bulbs of Lycoris radiata Fitoterapia 88 2013 82 90
24. S. López, J. Bastida, F. Viladomat, and C. Codina Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts Life Sci. 71 2002 2521 2529
25. A. Lopez-Tobón, E. Cepeda-Prado, and G.P. Cardona-Gómez Decrease of Tau hyperphosphorylation by 17β estradiol requires sphingosine kinase in a glutamate toxicity model Neurochem. Res. 34 2009 2206 2214
26. J. McNulty, J.J. Nair, J.R.L. Little, J.D. Brennan, and J. Bastida Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids Bioorg. Med. Chem. Lett. 20 2010 5290 5294
27. S.I. Mota, I.L. Ferreira, and A.C. Rego Dysfunctional synapse in Alzheimer's disease - a focus on NMDA receptors Neuropharmacology 76 2014 16 26
28. J.E. Ortiz, S. Berkov, N.B. Pigni, C. Theoduloz, G. Roitman, and A. Tapia Wild Argentinian Amaryllidaceae, a new renewable source of the acetylcholinesterase inhibitor galanthamine and other alkaloids Molecules 17 2012 13473 13482
29. E. Osorio, S. Robledo, and J. Bastida Alkaloids with antiprotozoal activity G.A. Cordell, The Alkaloids Chemistry and Biology 2008 Elsevier-Academic Press New York 113 190
30. R.A. Posada-Duque, D. Velasquez-Carvajal, G.P. Eckert, and G.P. Cardona-Gomez Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity Neurochem. Int. 62 2013 433 445
31. M. Racchi, M. Mazzucchelli, E. Porrello, C. Lanni, and S. Govoni Acetylcholinesterase inhibitors: novel activities of old molecules Pharmacol. Res. 50 2004 441 451
32. M. Rodríguez, F. Bernal, N. Andrés, Y. Malpesa, and N. Mahy Excitatory amino acids and neurodegeneration: a hypothetical role of calcium precipitation Int. J. Dev. Neurosci. 18 2000 299 307
33. Y. Shirasaki, M. Sugimura, and T. Sato Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal Eur. J. Pharmacol. 643 2010 48 57
34. S. Siegel, G. Sanacora, N.W. Hu, T. Ondrejcak, and M.J. Rowan Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances Pharmacol. Biochem. Behav. 100 2012 855 862
35. Y. Takada-Takatori, T. Kume, M. Sugimoto, H. Katsuki, T. Niidome, and H. Sugimoto Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity Eur. J. Pharmacol. 549 2006 19 26
36. M. Taveira, C. Sousa, P. Valentão, F. Ferreres, J.P. Teixeira, and P.B. Andrade Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress J. Steroid Biochem. 140 2014 106 115
37. W.M. Wu, Y.Y. Zhu, H.R. Li, H.Y. Yu, P. Zhang, and H.F. Pi Two new alkaloids from the bulbs of Lycoris sprengeri J. Asian Nat. Prod. Res. 16 2014 192 199
38. S. Yu, Q. Cheng, L. Li, M. Liu, Y. Yang, and F. Ding 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3 Toxicol. Appl. Pharmacol. 277 2014 259 269
39. C.A. Zarate, and H.K. Manji The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases Exp. Neurol. 211 2008 7 10
40. J.Y. Zhou, and S.W. Zhou Isorhynchophylline: a plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases Fitoterapia 83 2012 617 626